Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Other Operating Expenses (2019 - 2025)

Historic Other Operating Expenses for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $12.9 million.

  • Outset Medical's Other Operating Expenses fell 1664.62% to $12.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $54.4 million, marking a year-over-year decrease of 2239.02%. This contributed to the annual value of $54.4 million for FY2025, which is 2239.02% down from last year.
  • Latest data reveals that Outset Medical reported Other Operating Expenses of $12.9 million as of Q4 2025, which was down 1664.62% from $13.6 million recorded in Q3 2025.
  • Outset Medical's Other Operating Expenses' 5-year high stood at $25.0 million during Q2 2023, with a 5-year trough of $12.9 million in Q4 2025.
  • Its 5-year average for Other Operating Expenses is $18.8 million, with a median of $19.3 million in 2022.
  • In the last 5 years, Outset Medical's Other Operating Expenses surged by 8056.85% in 2021 and then crashed by 3763.35% in 2024.
  • Outset Medical's Other Operating Expenses (Quarter) stood at $23.0 million in 2021, then increased by 2.78% to $23.6 million in 2022, then decreased by 6.08% to $22.2 million in 2023, then plummeted by 30.38% to $15.5 million in 2024, then dropped by 16.65% to $12.9 million in 2025.
  • Its Other Operating Expenses stands at $12.9 million for Q4 2025, versus $13.6 million for Q3 2025 and $14.3 million for Q2 2025.